ARTICLE | Clinical News
Tivantinib: Phase II data
January 23, 2012 8:00 AM UTC
A double-blind, international Phase II trial in 107 patients with unresectable HCC who failed 1 prior systemic therapy showed that twice-daily oral tivantinib met the primary endpoint of significantly...